New Formulations of Methylphenidate for the Treatment of Attention-Deficit/Hyperactivity Disorder: Pharmacokinetics, Efficacy, and Tolerability
Crossref DOI link: https://doi.org/10.1007/s40263-017-0409-0
Published Online: 2017-01-28
Published Print: 2017-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Cortese, Samuele
D’Acunto, Giulia
Konofal, Eric
Masi, Gabriele
Vitiello, Benedetto
License valid from 2017-01-28